Skip to main content
Top
Published in: Head and Neck Pathology 4/2022

08-07-2022 | Lymphoma | Original Paper

Proposal of Diagnostic Approach of Periodontal Primary Non Hodgkin Lymphoma of Bone with Flow Cytometry as an Essential Diagnostic Component

Authors: Pooja Bhakta, Ayman Youssef, Lindsay Bigham, Jayati Mallick, Peeyush Bhargava, Faisal Rawas, Dylan Weaver, Zachary E. Hunzeker, Jianli Dong, Maurice Willis, Suimin Qiu, Ranjana Nawgiri, Chukwuemeka-chi C. Iguh, Kirill A. Lyapichev

Published in: Head and Neck Pathology | Issue 4/2022

Login to get access

Abstract

Background

Primary bone lymphoma is a rare type of lymphoid neoplasm with favorable prognosis, where Primary Non Hodgkin Lymphoma of bone (PB-NHL) is most common with the subtype. Amongst PB-NHL, diffuse large Bcell lymphoma represents the majority of cases. The mandible is a very uncommon site of involvement, presenting as a painful bone mass with high suspicion of osteomyelitis.

Methods

We report the case of a 45-year-old male with no significant past medical history who was admitted to the hospital with a large right jaw mass and pain after recent tooth removal. The original tissue biopsy was not diagnostic, and cultures were found to be negative for microorganisms. Due to enlargement of the mass, a fine needle aspiration (FNA) was done. At the time of rapid onsite evaluation of the FNA, atypical lymphoid cells were seen, and material was obtained for flow cytometry (FC) evaluation. This revealed an aberrant clonal B-cell population. The consequent immunohistochemical evaluation of original material supported the diagnosis of PB-NHL. After chemotherapy patient improved.

Results

After an extensive English language literature review, we identified and summarized the clinical presentations, diagnostic procedures, histopathologic features, treatment methods, and outcomes of forty-two cases of periodontal PB-NHL. Based on our findings, we propose a set of clinical features at initial presentation to increase the clinical suspicion of periodontal PB-NHL for practitioners.

Conclusion

Based on our institution’s experience and the literature review conclusions, we propose the University of Texas Medical Branch diagnostic approach for PB-NHL and suggest that FNA and FC should be utilized as the essential diagnostic component. The fast and efficient diagnosis of PB-NHL can facilitate the correct treatment and sufficiently improve patient care.
Literature
1.
go back to reference The WHO Classification of Tumours Editorial Board. WHO classification of tumours soft tissue and bone tumours. 5th ed. 2020: International Agency for Research on Cancer (IARC). The WHO Classification of Tumours Editorial Board. WHO classification of tumours soft tissue and bone tumours. 5th ed. 2020: International Agency for Research on Cancer (IARC).
2.
go back to reference Kitsoulis P, et al. Primary lymphomas of bone. Anticancer Res. 2006;26(1A):325–37. Kitsoulis P, et al. Primary lymphomas of bone. Anticancer Res. 2006;26(1A):325–37.
3.
go back to reference Wu H, et al. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience. Br J Haematol. 2014;166(1):60–8.CrossRef Wu H, et al. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience. Br J Haematol. 2014;166(1):60–8.CrossRef
4.
go back to reference Li X, et al. Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-cell lymphoma derived from centrocytes in the germinal center. Am J Surg Pathol. 2017;41(10):1309–21.CrossRef Li X, et al. Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-cell lymphoma derived from centrocytes in the germinal center. Am J Surg Pathol. 2017;41(10):1309–21.CrossRef
5.
go back to reference Messina C, et al. Primary and secondary bone lymphomas. Cancer Treat Rev. 2015;41(3):235–46.CrossRef Messina C, et al. Primary and secondary bone lymphomas. Cancer Treat Rev. 2015;41(3):235–46.CrossRef
6.
go back to reference Bruno Ventre M, et al. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist. 2014;19(3):291–8.CrossRef Bruno Ventre M, et al. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist. 2014;19(3):291–8.CrossRef
7.
go back to reference Tao R, et al. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2015;92(1):122–9.CrossRef Tao R, et al. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2015;92(1):122–9.CrossRef
8.
go back to reference Kluin PM, et al. Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobated nuclei. Cancer. 1984;54(8):1598–605.CrossRef Kluin PM, et al. Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobated nuclei. Cancer. 1984;54(8):1598–605.CrossRef
9.
go back to reference Gusenbauer AW, Katsikeris NF, Brown A. Primary lymphoma of the mandible: report of a case. J Oral Maxillofac Surg. 1990;48(4):409–15.CrossRef Gusenbauer AW, Katsikeris NF, Brown A. Primary lymphoma of the mandible: report of a case. J Oral Maxillofac Surg. 1990;48(4):409–15.CrossRef
10.
go back to reference Bertolotto M, et al. Primary lymphoma of the mandible with diffuse widening of the mandibular canal: report of a case. Eur Radiol. 1996;6(5):637–9.CrossRef Bertolotto M, et al. Primary lymphoma of the mandible with diffuse widening of the mandibular canal: report of a case. Eur Radiol. 1996;6(5):637–9.CrossRef
11.
go back to reference Rios-Martin JJ, et al. Mandibular lymphomas with sclerosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(3):321–7.CrossRef Rios-Martin JJ, et al. Mandibular lymphomas with sclerosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(3):321–7.CrossRef
12.
go back to reference Parrington SJ, Punnia-Moorthy A. Primary non-Hodgkin’s lymphoma of the mandible presenting following tooth extraction. Br Dent J. 1999;187(9):468–70.CrossRef Parrington SJ, Punnia-Moorthy A. Primary non-Hodgkin’s lymphoma of the mandible presenting following tooth extraction. Br Dent J. 1999;187(9):468–70.CrossRef
13.
go back to reference Kirita T, et al. Primary non-Hodgkin’s lymphoma of the mandible treated with radiotherapy, chemotherapy, and autologous peripheral blood stem cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(4):450–5.CrossRef Kirita T, et al. Primary non-Hodgkin’s lymphoma of the mandible treated with radiotherapy, chemotherapy, and autologous peripheral blood stem cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(4):450–5.CrossRef
14.
go back to reference Pazoki A, Jansisyanont P, Ord RA. Primary non-Hodgkin’s lymphoma of the jaws: report of 4 cases and review of the literature. J Oral Maxillofac Surg. 2003;61(1):112–7.CrossRef Pazoki A, Jansisyanont P, Ord RA. Primary non-Hodgkin’s lymphoma of the jaws: report of 4 cases and review of the literature. J Oral Maxillofac Surg. 2003;61(1):112–7.CrossRef
15.
go back to reference Longo F, et al. Primary non-Hodgkin’s lymphoma of the mandible. Report of a case. Int J Oral Maxillofac Surg. 2004;33(8):801–3.CrossRef Longo F, et al. Primary non-Hodgkin’s lymphoma of the mandible. Report of a case. Int J Oral Maxillofac Surg. 2004;33(8):801–3.CrossRef
16.
go back to reference Rosado MF, et al. Primary diffuse large cell lymphoma of the mandible. Leuk Lymphoma. 2004;45(5):1049–53.CrossRef Rosado MF, et al. Primary diffuse large cell lymphoma of the mandible. Leuk Lymphoma. 2004;45(5):1049–53.CrossRef
17.
go back to reference Adouani A, et al. B-cell lymphoma of the mandible: a case report. Clin Med Oncol. 2008;2:445–50. Adouani A, et al. B-cell lymphoma of the mandible: a case report. Clin Med Oncol. 2008;2:445–50.
18.
go back to reference Bosch-Barrera J, et al. Primary bone lymphoma of the mandible and thyroid incidentaloma identified by FDG PET/CT: a case report. Cases J. 2009;2:6384. Bosch-Barrera J, et al. Primary bone lymphoma of the mandible and thyroid incidentaloma identified by FDG PET/CT: a case report. Cases J. 2009;2:6384.
19.
go back to reference Kini R, Saha A, Naik V. Diffuse large B-cell lymphoma of mandible: a case report. Med Oral Patol Oral Cir Bucal. 2009;14(9):e421–4. Kini R, Saha A, Naik V. Diffuse large B-cell lymphoma of mandible: a case report. Med Oral Patol Oral Cir Bucal. 2009;14(9):e421–4.
20.
go back to reference Niscola P, et al. Primary anaplastic large B-cell lymphoma in mandible: long-term complete remission with R-CHOP regimen and involved field radiotherapy. Oral Oncol. 2009;45(9): e113.CrossRef Niscola P, et al. Primary anaplastic large B-cell lymphoma in mandible: long-term complete remission with R-CHOP regimen and involved field radiotherapy. Oral Oncol. 2009;45(9): e113.CrossRef
21.
go back to reference Buric N, et al. Radiographic enlargement of mandibular canal as first feature of non-Hodgkin’s lymphoma. Dentomaxillofac Radiol. 2010;39(6):383–8.CrossRef Buric N, et al. Radiographic enlargement of mandibular canal as first feature of non-Hodgkin’s lymphoma. Dentomaxillofac Radiol. 2010;39(6):383–8.CrossRef
22.
go back to reference Dinakar J, Priya L, Reddy S. Primary non-Hodgkin’s lymphoma of the mandible. J Oral Maxillofac Pathol. 2010;14(2):73–6.CrossRef Dinakar J, Priya L, Reddy S. Primary non-Hodgkin’s lymphoma of the mandible. J Oral Maxillofac Pathol. 2010;14(2):73–6.CrossRef
23.
go back to reference Kalkanis D, et al. Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate. Clin Nucl Med. 2010;35(1):24–5.CrossRef Kalkanis D, et al. Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate. Clin Nucl Med. 2010;35(1):24–5.CrossRef
24.
go back to reference Agrawal MG, Agrawal SM, Kambalimath DH. Non-Hodgkins lymphoma of maxilla: a rare entity. Natl J Maxillofac Surg. 2011;2(2):210–3.CrossRef Agrawal MG, Agrawal SM, Kambalimath DH. Non-Hodgkins lymphoma of maxilla: a rare entity. Natl J Maxillofac Surg. 2011;2(2):210–3.CrossRef
25.
go back to reference Batth, J.S., et al., Mandibular swelling as the first manifestation of Non Hodgkin’s lymphoma: a case report. Int J Contemp Dent, 2011. 2. Batth, J.S., et al., Mandibular swelling as the first manifestation of Non Hodgkin’s lymphoma: a case report. Int J Contemp Dent, 2011. 2.
26.
go back to reference Velez I, Hogge M. Primary maxillofacial large B-cell lymphoma in immunocompetent patients: report of 5 cases. Case Rep Radiol. 2011;2011: 108023. Velez I, Hogge M. Primary maxillofacial large B-cell lymphoma in immunocompetent patients: report of 5 cases. Case Rep Radiol. 2011;2011: 108023.
27.
go back to reference Nayak PB, et al. Centroblastic variant of diffuse large B-cell lymphoma: case report and review of literature. J Oral Maxillofac Pathol. 2013;17(2):261–5.CrossRef Nayak PB, et al. Centroblastic variant of diffuse large B-cell lymphoma: case report and review of literature. J Oral Maxillofac Pathol. 2013;17(2):261–5.CrossRef
28.
go back to reference Parihar S, Garg RK, Narain P. Primary extra-nodal non-Hodgkin’s lymphoma of gingiva: a diagnostic dilemma. J Oral Maxillofac Pathol. 2013;17(2):320.CrossRef Parihar S, Garg RK, Narain P. Primary extra-nodal non-Hodgkin’s lymphoma of gingiva: a diagnostic dilemma. J Oral Maxillofac Pathol. 2013;17(2):320.CrossRef
29.
go back to reference Cortese A, et al. Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies. Int J Surg. 2014;12(Suppl 2):S23–8.CrossRef Cortese A, et al. Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies. Int J Surg. 2014;12(Suppl 2):S23–8.CrossRef
30.
go back to reference Okahata R, et al. Diffuse large B-cell lymphoma of the mandible with periosteal reaction: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(2):e228–32.CrossRef Okahata R, et al. Diffuse large B-cell lymphoma of the mandible with periosteal reaction: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(2):e228–32.CrossRef
31.
go back to reference Alshahrani FA, et al. Primary diffuse large B-cell lymphoma involving the mandible. J Contemp Dent Pract. 2015;16(10):840–4.CrossRef Alshahrani FA, et al. Primary diffuse large B-cell lymphoma involving the mandible. J Contemp Dent Pract. 2015;16(10):840–4.CrossRef
32.
go back to reference Bugshan A, Kassolis J, Basile J. Primary diffuse large B-cell lymphoma of the mandible: case report and review of the literature. Case Rep Oncol. 2015;8(3):451–5.CrossRef Bugshan A, Kassolis J, Basile J. Primary diffuse large B-cell lymphoma of the mandible: case report and review of the literature. Case Rep Oncol. 2015;8(3):451–5.CrossRef
33.
go back to reference Pelletier-Galarneau M, et al. False negative (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in primary B-cell lymphoma of the bone. World J Nucl Med. 2017;16(2):166–8.CrossRef Pelletier-Galarneau M, et al. False negative (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in primary B-cell lymphoma of the bone. World J Nucl Med. 2017;16(2):166–8.CrossRef
34.
go back to reference Neerupakam M, et al. Non-Hodgkin’s lymphoma of the mandible in HIV patient—a rare case report. Contemp Clin Dent. 2018;9(1):110–3. Neerupakam M, et al. Non-Hodgkin’s lymphoma of the mandible in HIV patient—a rare case report. Contemp Clin Dent. 2018;9(1):110–3.
35.
go back to reference Zou H, et al. Primary diffuse large B-cell lymphoma in the maxilla: a case report. Medicine (Baltimore). 2018;97(20): e10707.CrossRef Zou H, et al. Primary diffuse large B-cell lymphoma in the maxilla: a case report. Medicine (Baltimore). 2018;97(20): e10707.CrossRef
36.
go back to reference Silva RNF, et al. T-Cell/histiocyte-rich large B-cell lymphoma: report of the first case in the mandible. Head Neck Pathol. 2019;13(4):711–7.CrossRef Silva RNF, et al. T-Cell/histiocyte-rich large B-cell lymphoma: report of the first case in the mandible. Head Neck Pathol. 2019;13(4):711–7.CrossRef
37.
go back to reference Siqueira JM, et al. Primary diffuse large B-cell lymphoma of the mandible. Autops Case Rep. 2019;9(3): e2019109.CrossRef Siqueira JM, et al. Primary diffuse large B-cell lymphoma of the mandible. Autops Case Rep. 2019;9(3): e2019109.CrossRef
38.
go back to reference Fatahzadeh M. Primary diffuse large B-cell lymphoma of mandible masquerading as a toothache. Quintessence Int. 2020;51(1):50–5. Fatahzadeh M. Primary diffuse large B-cell lymphoma of mandible masquerading as a toothache. Quintessence Int. 2020;51(1):50–5.
39.
go back to reference Xie H, et al. (18)F-FDG PET/CT imaging for a solitary primary bone lymphoma of the maxilla. Hell J Nucl Med. 2020;23(3):358–9. Xie H, et al. (18)F-FDG PET/CT imaging for a solitary primary bone lymphoma of the maxilla. Hell J Nucl Med. 2020;23(3):358–9.
40.
go back to reference Heyning FH, et al. Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone. J Clin Pathol. 2010;63(12):1095–100.CrossRef Heyning FH, et al. Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone. J Clin Pathol. 2010;63(12):1095–100.CrossRef
41.
go back to reference Mikhail FM, et al. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC). Genet Med. 2019;21(9):1903–16.CrossRef Mikhail FM, et al. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC). Genet Med. 2019;21(9):1903–16.CrossRef
42.
go back to reference Jawad MU, et al. Primary lymphoma of bone in adult patients. Cancer. 2010;116(4):871–9.CrossRef Jawad MU, et al. Primary lymphoma of bone in adult patients. Cancer. 2010;116(4):871–9.CrossRef
43.
go back to reference Fritschy JM. Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur J Neurosci. 2008;28(12):2365–70.CrossRef Fritschy JM. Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur J Neurosci. 2008;28(12):2365–70.CrossRef
44.
go back to reference True LD. Quality control in molecular immunohistochemistry. Histochem Cell Biol. 2008;130(3):473–80.CrossRef True LD. Quality control in molecular immunohistochemistry. Histochem Cell Biol. 2008;130(3):473–80.CrossRef
45.
go back to reference Matos LL, et al. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010;5:9–20.CrossRef Matos LL, et al. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010;5:9–20.CrossRef
46.
go back to reference Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med. 2008;132(3):441–61.CrossRef Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med. 2008;132(3):441–61.CrossRef
47.
go back to reference Bhagavathi S, Fu K. Primary lymphoma of bone: a review. Semin Diagn Pathol. 2014;31(1):48–52.CrossRef Bhagavathi S, Fu K. Primary lymphoma of bone: a review. Semin Diagn Pathol. 2014;31(1):48–52.CrossRef
48.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer IARC; 2017. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer IARC; 2017.
49.
go back to reference Corti M, et al. An aggressive plasmablastic lymphoma of the oral cavity as primary manifestation of acquired immunodeficiency syndrome: case report and literature review. Int Arch Otorhinolaryngol. 2015;19(4):354–8.CrossRef Corti M, et al. An aggressive plasmablastic lymphoma of the oral cavity as primary manifestation of acquired immunodeficiency syndrome: case report and literature review. Int Arch Otorhinolaryngol. 2015;19(4):354–8.CrossRef
50.
go back to reference Kayahara GM, et al. HIV-related plasmablastic lymphoma causing extensive bone destruction in the mandible. Oral Oncol. 2022;126: 105761.CrossRef Kayahara GM, et al. HIV-related plasmablastic lymphoma causing extensive bone destruction in the mandible. Oral Oncol. 2022;126: 105761.CrossRef
51.
go back to reference Colomo L, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28(6):736–47.CrossRef Colomo L, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28(6):736–47.CrossRef
52.
go back to reference Delecluse HJ, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89(4):1413–20.CrossRef Delecluse HJ, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89(4):1413–20.CrossRef
53.
go back to reference Morscio J, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol. 2014;38(7):875–86.CrossRef Morscio J, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol. 2014;38(7):875–86.CrossRef
54.
go back to reference Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125(15):2323–30.CrossRef Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125(15):2323–30.CrossRef
55.
go back to reference Silveira HA, et al. Primary intraosseous CD9-positive B-cell lymphoblastic lymphoma of the maxilla affecting a pediatric patient: Immunohistochemical and in situ hybridization analysis. Oral Oncol. 2020;108: 104910.CrossRef Silveira HA, et al. Primary intraosseous CD9-positive B-cell lymphoblastic lymphoma of the maxilla affecting a pediatric patient: Immunohistochemical and in situ hybridization analysis. Oral Oncol. 2020;108: 104910.CrossRef
56.
go back to reference Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46(197):218–23.CrossRef Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46(197):218–23.CrossRef
57.
go back to reference Wright DH. Burkitt’s lymphoma: a review of the pathology, immunology, and possible etiologic factors. Pathol Annu. 1971;6:337–63. Wright DH. Burkitt’s lymphoma: a review of the pathology, immunology, and possible etiologic factors. Pathol Annu. 1971;6:337–63.
58.
go back to reference Hans CP, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–82.CrossRef Hans CP, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–82.CrossRef
59.
go back to reference Staiger AM, et al. Clinical impact of the cell-of-origin classification and the MYC/BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the German high-grade non-Hodgkin’s Lymphoma Study Group. J Clin Oncol. 2017;35(22):2515–26.CrossRef Staiger AM, et al. Clinical impact of the cell-of-origin classification and the MYC/BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the German high-grade non-Hodgkin’s Lymphoma Study Group. J Clin Oncol. 2017;35(22):2515–26.CrossRef
60.
go back to reference de Groen RAL, et al. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. Blood Adv. 2021;5(19):3760–75. de Groen RAL, et al. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. Blood Adv. 2021;5(19):3760–75.
61.
go back to reference Sharma A, et al. Primary bone lymphoma: a 13 year retrospective institutional analysis in the chemo-immunotherapy era. Indian J Hematol Blood Transfus. 2021;37(2):240–8.CrossRef Sharma A, et al. Primary bone lymphoma: a 13 year retrospective institutional analysis in the chemo-immunotherapy era. Indian J Hematol Blood Transfus. 2021;37(2):240–8.CrossRef
62.
go back to reference Ramadan KM, et al. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007;18(1):129–35.CrossRef Ramadan KM, et al. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007;18(1):129–35.CrossRef
63.
go back to reference Batoo SA, Sidhu GS. Primary bone lymphoma (PBL): impact of novel treatment on need for radiation therapy (RT), a population based study. Blood. 2013;122(21):3059.CrossRef Batoo SA, Sidhu GS. Primary bone lymphoma (PBL): impact of novel treatment on need for radiation therapy (RT), a population based study. Blood. 2013;122(21):3059.CrossRef
Metadata
Title
Proposal of Diagnostic Approach of Periodontal Primary Non Hodgkin Lymphoma of Bone with Flow Cytometry as an Essential Diagnostic Component
Authors
Pooja Bhakta
Ayman Youssef
Lindsay Bigham
Jayati Mallick
Peeyush Bhargava
Faisal Rawas
Dylan Weaver
Zachary E. Hunzeker
Jianli Dong
Maurice Willis
Suimin Qiu
Ranjana Nawgiri
Chukwuemeka-chi C. Iguh
Kirill A. Lyapichev
Publication date
08-07-2022

Other articles of this Issue 4/2022

Head and Neck Pathology 4/2022 Go to the issue